Clinical Trials Logo
  1. Home
  2. Breast Cancer
  3. NCT00839696
  4. Details
NCT00839696 Clinical Trial

Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk

Breast Cancer Risk Clinical Trial

Official title:
Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Risk

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00839696
Other study ID # CC07104
Secondary ID 2008-1013A538500
Status Completed
Phase
First received
Last updated
Start date July 2008
Est. completion date April 2010

Study information
Verified date December 2014
Source University of Wisconsin, Madison
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Mammographic density is sensitive to estorgen exposure and constitutes a strong intermediate maker of breast cancer risk. We hypothesize that women with higher serum xenoestrogen levels will have greater mammographic density.

Recruitment information / eligibility
Status Completed
Enrollment 270
Est. completion date April 2010
Est. primary completion date June 2009
Accepts healthy volunteers No
Gender Female
Age group 55 Years to 70 Years
Eligibility Inclusion Criteria:

- 55-70 years of age, Post menopausal

Exclusion Criteria:

- If they have ever used hormone replacment therapy or have ever used Tamoxifen or Raloxifene, Diag. with breast cancer have had breast implants or have had a mastectomy/

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States University of Wisconsin Hospital Madison Wisconsin

Sponsors (2)
Lead Sponsor Collaborator
University of Wisconsin, Madison United States Department of Defense

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Characterize the distribution of total xenoestrogen burden and identify important source of xenoestrogen exposure among a clinic-based sample of postmenopausal women. 1 year
Secondary Evaluate the association of total xenoestorgen exposure with mammographic density. 1 year
See also
  Status Clinical Trial Phase
Completed NCT03688204 - Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer
Active, not recruiting NCT04082117 - Uptake of Genetic Counseling Among African American Women N/A
Completed NCT05082740 - FH-Risk 2.0: Updating Breast Cancer Risk Estimates
Not yet recruiting NCT05848856 - The RISC Registry--Risk Informed Screening Registry
Recruiting NCT04248257 - Peer Support For Young Adult Women With High Breast Cancer Risk N/A
Enrolling by invitation NCT04265547 - Family-Based Intervention Study of the Effects of Environmental Exposures on Breast Tissue Composition N/A
Completed NCT01511276 - The Effects of Equivalent Weight Loss With or Without Exercise Training on Breast Cancer Risk (SHAPE-2) N/A
Completed NCT00555386 - Soy, Selenium and Breast Cancer Risk N/A

External Links